IMMUNITYBIO INC (IBRX:NASDAQ)
$6.89 -0.1 (-1.4306%)
Analysed IMMUNITYBIO INC (IBRX:NASDAQ) News Sources
ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last?
29-06-2026
yahoo.com
IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales
30-06-2026
stocktwits.com
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst
06-07-2026
stocktwits.com
Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise
10-07-2026
stocktwits.com
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout
10-07-2026
247wallst.com
IBRX Stock Climbs Premarket Despite Investor Stake Cut — Retail Sees ‘Imminent’ Global Rollout Catalyst
14-07-2026
stocktwits.com
SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot
16-07-2026
stocktwits.com
Is ImmunityBio (IBRX) Reasonably Valued After Its 283% Rally?
16-07-2026
yahoo.com
ImmunityBio (IBRX) Could Be 41% Undervalued On Anktiva Optimism
16-07-2026
yahoo.com
IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference
27-07-2026
stocktwits.com
What is the current price of IMMUNITYBIO INC (IBRX:NASDAQ)?
The current price of IMMUNITYBIO INC (IBRX:NASDAQ) is $6.89.
IMMUNITYBIO INC (IBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is $-0.1.
IMMUNITYBIO INC (IBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is -1.4306%.
What is the most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent sentiment for IMMUNITYBIO INC (IBRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNITYBIO INC (IBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.